Donald R. Lazarus

Donald R. Lazarus

Auto-generated profile, based on publicly available information

Donald R. Lazarus

Pulmonary, Critical Care, and Sleep Medicine Section, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
RCRoberto F. Casal
Roberto F. Casal
DLDonald R. Lazarus
Donald R. Lazarus
KKKristine Kuhl
Kristine Kuhl
GNGraciela Nogueras-González
Graciela Nogueras-González
SPSarah Perusich
Sarah Perusich
FKFarrah Kheradmand
Farrah Kheradmand
Rationale: Data about the influence of the type of sedation on yield, complications, and tolerance of endobronchial ultrasound–guided transbronchial needle aspiration (EBUS-TBNA) are based mostly on retrospective studies and are largely inconsistent. Objectives: To determine whether the type of sedation influences the diagnostic yield of EBUS-TBNA, its complication rates, and patient tolerance. Methods: Patients referred for EBUS-TBNA were randomized (1:1) to undergo this procedure under general anesthesia (GA) or moderate sedation (MS). Pathologists were blinded to group allocation. Measurements and Main Results: The main outcome was “diagnostic yield,” defined as the percentage of patients for whom EBUS-TBNA rendered a specific diagnosis. One hundred and forty-nine patients underwent EBUS-TBNA, 75 under GA and 74 under MS. Demographic and baseline clinical characteristics were well balanced. Two hundred and thirty-six lymph nodes (LNs) and six masses were sampled in the GA group (average, 3.2 ± 1.9 sites/patient), and 200 LNs and six masses in the MS group (average, 2.8 ± 1.5 sites/patient) (P = 0.199). The diagnostic yield was 70.7% (53 of 75) and 68.9% (51 of 74) for the GA group and MS group, respectively (P = 0.816). The sensitivity was 98.2% in the GA group (confidence interval, 97–100%) and 98.1% in the MS group (confidence interval, 97–100%) (P = 0.979). EBUS was completed in all patients in the GA group, and in 69 patients (93.3%) in the MS group (P = 0.028). There were no major complications or escalation of care in either group. Minor complications were more common in the MS group (29.6 vs. 5.3%) (P < 0.001). Most patients stated they “definitely would” undergo this procedure again in both groups (P = 0.355). Conclusions: EBUS-TBNA performed under MS results in comparable diagnostic yield, rate of major complications, and patient tolerance as under GA. Future prospective multicenter studies are required to corroborate our findings. Clinical trial registered with www.clinicaltrials.gov (NCT 01430962).

1 June 2014 in Chest
Verified
Journal Article
Closed access
DODavid Ost
David Ost
CJCarlos A. Jimenez
Carlos A. Jimenez
XLXiudong Lei
Xiudong Lei
SCScott B. Cantor
Scott B. Cantor
HGHoriana B. Grosu
Horiana B. Grosu
GEGeorge A. Eapen
George A. Eapen

9 March 2022 in Respiratory Medicine
Verified
Journal Article
Closed access
SBSami Isam Bashour
Sami Isam Bashour
BMBabith J. Mankidy
Babith J. Mankidy
DLDonald R. Lazarus
Donald R. Lazarus

1 June 2007 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
MGMatthew E. Griffith
Matthew E. Griffith
DLDonald R. Lazarus
Donald R. Lazarus
PMPaul B. Mann
Paul B. Mann
JBJohn A. Boger
John A. Boger
DHDuane R. Hospenthal
Duane R. Hospenthal
CMClinton K. Murray
Clinton K. Murray
Skin carriage ofAcinetobacter calcoaceticus-baumanniicomplex was not detected among a representative sample of 102 US Army soldiers stationed in Iraq. This observation refutes the hypothesis that preinjury skin carriage serves as the reservoir for theAcinetobacterinfections seen in US military combat casualties.

15 May 2023 in Respiratory Medicine
Verified
Journal Article
Closed access
BMBabith J. Mankidy
Babith J. Mankidy
MGMohammad Ghasemi-rad
Mohammad Ghasemi-rad
KTKelly Trinh
Kelly Trinh
AAAnoop Padoor Ayyappan
Anoop Padoor Ayyappan
QHQuillan Huang
Quillan Huang
DLDonald R. Lazarus
Donald R. Lazarus

31 May 2018 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
RYRan You
Ran You
FDFrancesco John DeMayo
Francesco John DeMayo
JLJian Liu
Jian Liu
SCSung-Nam Cho
Sung-Nam Cho
BBBryan M. Burt
Bryan M. Burt
FKFarrah Kheradmand
Farrah Kheradmand
Somatic mutations can promote malignant transformation of airway epithelial cells and induce inflammatory responses directed against resultant tumors. Tumor-infiltrating T lymphocytes (TIL) in early-stage non–small cell lung cancer (NSCLC) secrete distinct proinflammatory cytokines, but the contribution of these TILs to tumor development and metastasis remains unknown. We show here that TILs in early-stage NSCLC are biased toward IL17A expression (Th17) when compared with adjacent tumor-free tissue, whereas Th17 cells are decreased in tumor infiltrating locoregional lymph nodes in advanced NSCLC. Mice in which Pten and Smad4 (Pts4d/d) are deleted from airway epithelial cells develop spontaneous tumors, that share genetic signatures with squamous- (SQ.2b), and adeno- (AD.1) subtypes of human NSCLC. Pts4d/d mice globally lacking in IL17a (Pts4d/dIl17a–/–) showed decreased tumor latency and increased metastasis. Th17 cells were required for recruitment of CD103+ dendritic cells, and adoptive transfer of IL17a-sufficient CD4+ T cells reversed early tumor development and metastasis in Pts4d/dIl17a–/– mice. Together, these findings support a key role for Th17 cells in TILs associated with the Pts4d/d model of NSCLC and suggest therapeutic and biomarker strategies for human SQ2b and AD1 lung cancer. Cancer Immunol Res; 6(6); 645–57. ©2018 AACR.